Centrinone-B
Centrinone-B (LCR-323) is a potent and selective Plk4 inhibitor used in cancer research. It has demonstrated activity in cellular assays and is a key tool for investigating centriole duplication and potential therapeutic strategies, such as in triple-negative breast cancer models.
Product Specifications
CAS Number
1798871-31-4
Product Name Alternative
LCR323, LCR-323, LCR 323, Centrinone-B, Centrinone B, CentrinoneB, Aurora B, Aurora A, Plk4, PLK4 G95L, PLK4
Field of Research
Cell Biology
Purity
98.71% (May vary between batches)
Solubility
H2O:< 0.1 mg/mL (insoluble) ;10% DMSO+90% Corn Oil:2 mg/mL (3.17 mM) ; DMSO:20 mg/mL (31.66 mM)
Smiles
COc1c (Nc2cc (C) [nH]n2) nc (Sc2ccc (cc2F) S (=O) (=O) Cc2cccc (c2F) [N+] ([O-]) =O) nc1N1CCCCC1
Molecular Formula
C27H27F2N7O5S2
Molecular Weight
631.67
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-10846M-BF750 100 µL
Bcl-2 Monoclonal Antibody, AbBy Fluor™ 750 Conjugated
Sign In for Pricing
View Details 
122926-AP 100 µL
ACTL7B (Actin-like Protein 7B, Actin-like-7-beta, Tact1) (AP) discontinued
Sign In for Pricing
View Details NBP2-70623 100 µg
Mouse Monoclonal Ephrin-A3 Antibody (OTI4A4) - Azide and BSA Free
Sign In for Pricing
View Details